|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-8-13
|
|
pubmed:abstractText |
Aspirin therapy is known to substantially reduce mortality and the rate of ischaemic complications after coronary artery bypass grafting (CABG). Rates of perioperative aspirin resistance cited in the literature are up to 50% and could be influenced by extracorporeal circulation. Thus, aspirin resistance after CABG may have a significant clinical relevance.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1365-2362
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
769-74
|
|
pubmed:meshHeading |
pubmed-meshheading:19674078-Aspirin,
pubmed-meshheading:19674078-Coronary Artery Bypass,
pubmed-meshheading:19674078-Drug Administration Schedule,
pubmed-meshheading:19674078-Drug Resistance,
pubmed-meshheading:19674078-Female,
pubmed-meshheading:19674078-Humans,
pubmed-meshheading:19674078-Male,
pubmed-meshheading:19674078-Platelet Aggregation,
pubmed-meshheading:19674078-Platelet Aggregation Inhibitors,
pubmed-meshheading:19674078-Platelet Function Tests,
pubmed-meshheading:19674078-Postoperative Period,
pubmed-meshheading:19674078-Preoperative Care,
pubmed-meshheading:19674078-Risk Assessment
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Postoperative development of aspirin resistance following coronary artery bypass.
|
|
pubmed:affiliation |
Department of Cardiac Surgery, Heartcenter, University of Leipzig, Leipzig, Germany. kempfert@web.de
|
|
pubmed:publicationType |
Journal Article,
In Vitro
|
